Leading the Way in Diabetes Care, and in the Discussion of How to Pay for It
FDA Tells Direct-to-Consumer Genetic Testing Company to Halt Marketing
FDA Lifts Avandia Restrictions, but Most Find Action Moot
Incretin Mimetics: Pros and Cons, and Emerging Agents in Diabetes Treatment
Drug Pipeline
Amid Uproar Over Term Artificial Pancreas, How Will Patients, Payers Respond?
Will NYC's New Mayor Follow Through on Soda Limits?
With Science Reaching Consensus on Health Effects of Sugary Drinks, Talk of Portion Caps and Taxes Gains Steam Globally
